VC-backed Genocea Names Chip Clark CEO

Cambridge, Mass.-based vaccine development company Genocea Biosciences has named Chip Clark president and chief executive officer. Clark joined the company last August as chief business officer. Genocea is backed by investors including Johnson & Johnson Development Corporation, Skyline Ventures, MP Healthcare Venture Management and Polaris Venture Partners.

PeopleNorth AmericaUSBriefs